Effect of high concentration plasma platelet-derived growth factor-C on coronary artery disease in patients with coronary heart disease
CSTR:
Author:
Affiliation:

Department of Cardiology, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China)

Clc Number:

R541.4

  • Article
  • | |
  • Metrics
  • |
  • Reference [21]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To research the connection between the changes of plasma platelet-derived growth factor C (PDGF-C) concentration and coronary heart disease and the degree of coronary artery disease. Methods The research includes 52 patients with acute coronary syndrome (ACS), 52 patients with stable angina pectoris (SAP), and 50 patients with normal angiography as the control group. Among patients with coronary heart disease (ACS and SAP), there were 60 cases of coronary artery multivessel disease, 25 cases of double vessel disease, and 19 cases of single vessel disease. The enzyme-linked immunosorbent assay (ELISA) method was used to determine the plasma PDGF-C concentration in each group of patients. The plasma PDGF-C concentration levels were compared between groups, and Spearman correlation analysis, Logistic regression analysis, and ROC curve were drawn. Results The concentration of PDGF-C in the ACS group and the SAP group was higher than that in the control group(P<0.05). The plasma PDGF-C concentration in the multivessel and double disease groups was higher than that in the single disease group(P<0.05). The results of Spearman correlation analysis indicated that there was a correlation between plasma PDGF-C concentration and Gensini score(r=0.163, P<0.05). Logistic regression analysis found that patients with high concentration of PDGF-C had a higher risk of coronary heart disease than patients with low concentration of PDGF-C (OR=1.6,5%CI 1.002~1.011). The area under the ROC curve of plasma PDGF-C concentration was 0.645, and the sensitivity was 77.88%.Conclusion High-concentration plasma PDGF-C may be a risk factor for coronary heart disease and may be related to the severity of coronary artery disease.

    Reference
    [1] Park KH, Park WJ.Endothelial dysfunction:clinical implications in cardiovascular disease and therapeutic approaches.J Korean Med Sci, 5,0(9):1213-1225.
    [2] Kazlauskas A.Pdgfs and their receptors.Gene, 2017, 614: 1-7.
    [3] Folestad E, Kunath A, Wgster D.Pdgf-c and pdgf-d signaling in vascular diseases and animal models.Mol Aspects Med, 8,2(1):1-11.
    [4] Roswall P, Bocci M, Bartoschek M, et al.Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling.Nat Med, 8,4(4):463-473.
    [5] Radiosa G, Jenni H, Seppo YH, et al.Isoform-specific modulation of inflammation induced by adenoviral mediated delivery of platelet-derived growth factors in the adult mouse heart.Plos One, 6,1(8):e0160930.
    [6] Lee C, Li X.Platelet-derived growth factor-C and -D in the cardiovascular system and diseases.Mol Aspects Med, 8,2(1):12-21.
    [7] Robert E, Poelmann, Gittenberger-de GAC.Hemodynamics in cardiac development.J Cardiovasc Dev Dis, 8,5(4):54-83.
    [8] Nanda V, Wang T, Pjanic M, et al.Functional regulatory mechanism of smooth muscle cell-restricted lmod1 coronary artery disease locus.PLoS Genet, 2018,14(11):1-28.
    [9] 高静, 刘相飞, 陈玉东.黄三角地区人群中PDGF-C基因多态性与冠心病的相关性.中国动脉硬化杂志, 6,4(9):944-948.
    [10] Van RCRC, Martin IV, Drescher A, et al.Identification of platelet-derived growth factor C as a mediator of both renal fibrosis and hypertension.Kidney Int, 9,5(5):1103-1119.
    [11] 温进坤.不要低估血管平滑肌细胞在动脉粥样硬化斑块形成中的作用.中国动脉硬化杂志, 8,6(7):649-654.
    [12] Wgster D, Zhu C, Bjrck HM, et al.Effects of pdgf-c and pdgf-d on monocyte migration and mm-2 and mm-9 expression.Atherosclerosis, 9,2(2):415-423.
    [13] Son D, Na YR, Hwang ES, et al.Platelet-derived growth factor-C (pdgf-c) induces anti-apoptotic effects on macrophages through akt and bad phosphorylation.J Biol Chem, 4,9(9):6225-6235.
    [14] Parisi L, Gini E, Baci D, et al.Macrophage polarization in chronic inflammatory diseases:killers or builders?.J Immunol Res, 8,8(1):1-25.
    [15] Yang Q, Wang Y, Pei G, et al.Bone marrow-derived ly6C-macrophages promote ischemia-induced chronic kidney disease.Cell Death Dis, 9,0(4):291-307.
    [16] Mouton AJ, Ma Y, Gonzalez OJR, et al.Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis.Basic Res Cardiol, 9,4(2):6-21.
    [17] Li Y, Hu D, Lv P, et al.Expression of platelet-derived growth factor-C in aqueous humor of patients with neovascular glaucoma and its correlation with vascular endothelial growth factor.Eur J Ophthalmol, 2019, 26(1):1-6.
    [18] Moriya J, Ferrara N.Inhibition of protein kinase C enhances angiogenes is induced by platelet-derived growth factor C in hyperglycemic endothelial cells.Cardiovasc Diabetol, 5,4(1):1-19.
    [19] Eicher JD, Wakabayashi Y, Vitseva O, et al.Characterization of the platelet transcriptome by rna sequencing in patients with acute myocardial infarction.Platelets, 2016, 27(3):230-239.
    [20] Zeng ZY, Gui C, Li L, et al.Effects of percutaneous coronary intervention on serum angiopoietin-2 in patients with coronary heart disease.Chin Med J (Engl), 6,9(6): 631-635.
    [21] Rampidis GP, Benetos G, Benz DC, et al.A guide for gensini score calculation.Atherosclerosis, 9,7(1):181-183.
    Cited by
Get Citation

TANG Jin, JING Jing, SONG Hengliang, XIE Yanhui, ZHU Wanjie, XIAO Mingyang, LI Guiqi, WAN Daguo. Effect of high concentration plasma platelet-derived growth factor-C on coronary artery disease in patients with coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(5):447-451.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 29,2019
  • Revised:August 30,2019
  • Online: May 26,2020
Article QR Code